ARTHROSTYLE
LIVE

Serial Number

79382588

Owner

Dr. Christoph Karl

Attorney

Gregory M. Lefkowitz

Filing Date

Oct 9, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ARTHROSTYLE Trademark

Serial Number: 79382588 • Registration: 7683059

ARTHROSTYLE is a trademark filed by Dr. Christoph Karl on October 9, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

Dr. Christoph Karl (3 trademarks)

Haldenstraße 1

Entity Type: 01

Trademark Details

Filing Date

October 9, 2023

Registration Date

February 11, 2025

Published for Opposition

December 24, 2024

Goods & Services

Printed matter, namely, brochures for patients and magazines with advertising, including for pharmacies and doctors, all the aforesaid relating to the prevention and treatment of bone diseases

Pharmaceuticals, in particular for the prevention and treatment of cartilage and bone diseases; chemical reagents for medical purposes, in particular for the prevention and treatment of cartilage and bone diseases; biological tissue cultures for medical purposes; medicines for human medical purposes for the treatment of cartilage and bone diseases; pharmaceutical preparation in the form of tablets, capsules, pastilles, and granules for the treatment of cartilage and bone diseases; ointments for the treatment of cartilage and bone diseases; injection solutions in the nature of analgesics for the treatment of cartilage and bone diseases; dietetic substances for human medical purposes, namely, dietetic foods adapted for medical use, in particular for the prevention and treatment of cartilage and bone diseases; therapeutic food for medical purposes, namely, dietetic foods adapted for medical use for the prevention and treatment of cartilage and bone diseases; medicinal drinks; dietary supplements, in particular for medical purposes; vitamin and multi-vitamin preparations, in particular for medical purposes; mineral supplements and mineral preparations, in particular for medical purposes; biological and chemical preparations for medical purposes for use in laboratories, pharmacies and medical practices for the prevention and treatment of cartilage and bone diseases; pre-filled syringes sold filled with pharmaceutical preparations for the prevention and treatment of cartilage and bone diseases

Surgical apparatus and instruments for medical and dental use infusion sets comprising vials for the purposes of medical infusions; medical analytical apparatus, namely, measuring apparatus for bone density and cartilage quality; mechanical implants, namely, artificial bones for implementation and and artificial joint implants and implants for the purpose of cartilage repair for use in human and veterinary medicine, in particular for the prevention and treatment of cartilage and bone diseases

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 19, 2025 FINO
NEW REPRESENTATIVE AT IB RECEIVED
Sep 4, 2025 NREP
FINAL DISPOSITION NOTICE SENT TO IB
Aug 28, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 28, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 11, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 19, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 31, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 31, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 11, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 24, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 26, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 26, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 26, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 26, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 26, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 7, 2024 TROA
REFUSAL PROCESSED BY IB
Jul 14, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 25, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jun 25, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 14, 2024 RFCR
NON-FINAL ACTION WRITTEN
May 29, 2024 CNRT
ASSIGNED TO EXAMINER
May 28, 2024 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Mar 30, 2024 NREP
APPLICATION FILING RECEIPT MAILED
Nov 11, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2023 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Nov 3, 2023 SDRC